-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
ashvattha
-
Ashvattha Therapeutics is planning a trial of OP-101 in Long Covid
A drug company called Ashvattha Therapeutics is working on a new drug candidate for long Covid, OP-101. Link: Ashvattha previews plans for long Covid trial in mid-2023 Key takeaways: OP-101 was originally developed for neurodegenerative disease They're discussing their plans with the FDA so...- RedFox
- Thread
- ashvattha drugs long covid nfl op-101 treatment
- Replies: 3
- Forum: Long Covid news